XML 25 R13.htm IDEA: XBRL DOCUMENT v3.26.1
STOCKHOLDERS’ DEFICIT
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE 5 – STOCKHOLDERS’ DEFICIT

 

The Company is authorized to issue 295,000,000 authorized shares of common stock with a par value of $0.001 as of March 31, 2026, and 2025, respectively. The Company had 28,053,090 and 27,657,679 issued and outstanding shares of common stock as of March 31, 2026, and 2025, respectively.

 

The Company also has 5,000,000 authorized shares of “blank check” preferred stock. As of March 31, 2026, the Company has designated 1000 shares of Series A Convertible Preferred Stock ($.001 par value) (the “Series A Preferred”) and has issued 150 shares of the Series A Preferred. On May 15, 2026, the Company issued seven additional shares of Series A Convertible Preferred Stock to CWR 1, LLC valued at $5,000 per share pursuant to the Series A Convertible Stock designation in satisfaction of a portion of the dividends due CWR and four additional shares of Series A Convertible Preferred Stock to Reprise Management, Inc. valued at $5,000 per share pursuant to the Series A Convertible Stock designation in satisfaction of a portion of the dividends due Reprise. (See Note 6 – Subsequent Events).